Status:
COMPLETED
Radiomics Multifactorial Biomarker for Pulmonary Nodules
Lead Sponsor:
Maastricht University
Collaborating Sponsors:
Affiliated Zhongshan Hospital of Dalian University
The Second Affiliated Hospital of Dalian Medical University
Conditions:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
18+ years
Brief Summary
The investigators aim to investigate the utility of radiomics to differentiate malignant nodules from benign nodules and invasive adenocarcinoma from non-invasive adenocarcinoma.
Detailed Description
With the development of computed tomography (CT) equipment and the increasing use of lung cancer screening programs with low-dose CT, a growing number of early-stage lung cancers were detected so that...
Eligibility Criteria
Inclusion
- intraoperative frozen section diagnosis and final pathology diagnosis are available
- preoperative standard non-enhanced CT is available
- Pathologically confirmed
Exclusion
- with a previous history of radiation therapy, chemotherapy or biopsy
- the time interval between the CT examination and surgery was more than two weeks
Key Trial Info
Start Date :
July 11 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2019
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT03872362
Start Date
July 11 2018
End Date
February 1 2019
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Affiliated Zhongshan Hospital of Dalian University
Dalian, Liaoning, China, 116000